These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9164579)

  • 41. Proconvulsive effect of vasopressin; mediation by a putative V2 receptor subtype in the central nervous system.
    Croiset G; De Wied D
    Brain Res; 1997 Jun; 759(1):18-23. PubMed ID: 9219858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of analogs of the C-terminal fragment of arginine-vasopressin on the dynamics of development of a conditioned active avoidance response in rats.
    Voskresenskaya OG; Titov SA; Kamenskii AA; Golubovich VP; Ashmarin IP
    Neurosci Behav Physiol; 1999; 29(2):205-10. PubMed ID: 10432510
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Arginine-vasopressin content of hippocampus and amygdala during passive avoidance behavior in rats.
    Laczi F; Gaffori O; De Kloet ER; De Wied D
    Brain Res; 1983 Dec; 280(2):309-15. PubMed ID: 6652491
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Central target for the behavioural effects of vasopressin neuropeptides.
    de Wied D; Gaffori O; van Ree JM; de Jong W
    Nature; 1984 Mar 15-21; 308(5956):276-8. PubMed ID: 6322010
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Arginine vasopressin, stress, and memory.
    Koob GF; Lebrun C; Martinez JL; Dantzer R; Le Moal M; Bloom FE
    Ann N Y Acad Sci; 1985; 444():194-202. PubMed ID: 3860087
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Osmotic stress mimics effects of vasopressin on learned behaviour.
    Koob GF; Dantzer R; Rodriguez F; Bloom FE; Le Moal M
    Nature; 1985 Jun 27-Jul 3; 315(6022):750-2. PubMed ID: 4010780
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 6-OHDA bilateral lesions to the nucleus septi lateralis attenuate vasopressin improvement of recall in rats.
    Winnicka MM; Wiśniewski K
    Pharmacol Res; 1998 Feb; 37(2):145-50. PubMed ID: 9572070
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological characterization of a novel AVP(4-9) binding site in rat hippocampus.
    Nakayama Y; Takano Y; Shimohigashi Y; Tanabe S; Fujita T; Kamiya H; Tsujimoto G
    Brain Res; 2000 Mar; 858(2):416-23. PubMed ID: 10708695
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of pretraining administration of NC-1900, a vasopressin fragment analog, on memory performance in non- or CO2-amnesic mice.
    Sato T; Tanaka K; Teramoto T; Ohnishi Y; Hirate K; Irifune M; Nishikawa T
    Pharmacol Biochem Behav; 2004 Jun; 78(2):309-17. PubMed ID: 15219772
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vasopressin antagonists block peripheral as well as central vasopressin receptors.
    De Wied D; Gaffori O; Van Ree JM; De Jong W
    Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vasopressin and memory: the influence of prior experience with the training situation.
    Rigter H
    Behav Neural Biol; 1982 Apr; 34(4):337-51. PubMed ID: 7126085
    [No Abstract]   [Full Text] [Related]  

  • 52. Effects of peripherally injected vasopressin and des-glycinamide vasopressin on the extinction of a spatial learning task in rats.
    Packard MG; Ettenberg A
    Regul Pept; 1985 May; 11(1):51-63. PubMed ID: 4011956
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of vasopressin analogue [d(CH2)5(1),Tyr(Me)2]AVP on memory process in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Acta Neurobiol Exp (Wars); 1995; 55(3):207-11. PubMed ID: 8553914
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aversive effects of subcutaneously injected vasopressin in the rat: independence of the ascending dorsal noradrenergic bundle.
    Tam FW; Chen C; Alpert JE; Iversen SD
    Brain Res; 1985 Jun; 337(1):133-7. PubMed ID: 3924347
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MSH/ACTH4-10: a tool to differentiate between the role of vasopressin in memory consolidation or retrieval processes.
    van Wimersma Greidanus T
    Peptides; 1982; 3(1):7-11. PubMed ID: 6281748
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Arginine vasopressin fragment AVP(4-9)facilitates induction of long-term potentiation in the hippocampus.
    Chepkova AN; Kapai NA; Skrebitskii VG
    Bull Exp Biol Med; 2001 Feb; 131(2):136-8. PubMed ID: 11391395
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The improvement of memory retention and retrieval of a novel vasopressin fragment analog NC-1900].
    Sato T; Tanaka K; Ohnishi Y; Teramoto T; Hirate K; Nishikawa T
    Nihon Yakurigaku Zasshi; 2002 Nov; 120(1):57P-60P. PubMed ID: 12491780
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Septal vasopressin modulates motility and passive avoidance in pinealectomized rats.
    Appenrodt E; Schwarzberg H
    Physiol Behav; 1999 Jul; 66(5):757-61. PubMed ID: 10405103
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Enhancement of NGF gene expression in rat brain by the memory-enhancing peptide AVP(4-8).
    Zhou AW; Guo J; Wang HY; Gu BX; Du YC
    Peptides; 1995; 16(4):581-6. PubMed ID: 7479287
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential responses in immunoreactive arginine-vasopressin content of microdissected brain regions during passive avoidance behavior.
    Laczi F; Gaffori O; de Kloet ER; de Wied D
    Brain Res; 1983 Feb; 260(2):342-6. PubMed ID: 6831206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.